{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:53:45Z","timestamp":1760298825976},"reference-count":23,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-13-0918","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T23:06:48Z","timestamp":1384297608000},"page":"248-255","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of Effects of \u03b1-Glucosidase Inhibitors and Glinide Drugs on Endothelial Dysfunction in Diabetic Patients With Coronary Artery Disease"],"prefix":"10.1253","volume":"78","author":[{"given":"Takahiro","family":"Sawada","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Himeji Brain and Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Shiotani","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Kobe University Graduate School of Preventive Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Terashita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Awaji Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Awaji Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-shiku","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Awaji Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Koide","sequence":"additional","affiliation":[{"name":"Koide Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Himeji Brain and Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":" 1. ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011; 364: 818–828.","DOI":"10.1056\/NEJMoa1006524"},{"key":"2","doi-asserted-by":"crossref","unstructured":" 2. Emoto T, Sawada T, Hashimoto M, Kageyama H, Terashita D, Mizoguchi T, et al. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease. Am J Cardiol 2012; 109: 42–46.","DOI":"10.1016\/j.amjcard.2011.08.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":" 3. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M. The STOP-NIDDM Trial: An international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care 1998; 21: 1720–1725.","DOI":"10.2337\/diacare.21.10.1720"},{"key":"4","doi-asserted-by":"crossref","unstructured":" 4. Hanefeld M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10–16.","DOI":"10.1016\/S0195-668X(03)00468-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":" 5. Hirano M, Nakamura T, Obata JE, Fujioka D, Saito Y, Kawabata K, et al. Early improvement in carotid plaque echogenicity by acarbose in patients with acute coronary syndromes. Circ J 2012; 76: 1452–1460.","DOI":"10.1253\/circj.CJ-11-1524"},{"key":"6","doi-asserted-by":"crossref","unstructured":" 6. NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362: 1463–1476.","DOI":"10.1056\/NEJMoa1001122"},{"key":"7","doi-asserted-by":"crossref","unstructured":" 7. Kataoka Y, Yasuda S, Miyamoto Y, Sase K, Kosuge M, Kimura K, et al. Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients. Circ J 2012; 76: 712–720.","DOI":"10.1253\/circj.CJ-11-1011"},{"key":"8","doi-asserted-by":"crossref","unstructured":" 8. Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: A review of recommendations. Diabet Med 2008; 25: 1151–1156.","DOI":"10.1111\/j.1464-5491.2008.02565.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":" 9. Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride\/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 2003; 10: 186–191.","DOI":"10.5551\/jat.10.186"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nicholls SJ, Tuzcu EM, Wolski K, Bayturan O, Lavoie A, Uno K, et al. Lowering the triglyceride\/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: Insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study. J Am Coll Cardiol 2011; 57: 153–159.","DOI":"10.1016\/j.jacc.2010.06.055"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004; 109: IV6–IV19.","DOI":"10.1161\/01.CIR.0000133444.17867.56"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673–2678.","DOI":"10.1161\/hc4601.099485"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D’Ambrosio A, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 2005; 111: 70–75.","DOI":"10.1161\/01.CIR.0000151308.06673.D2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sawada T, Emoto T, Motoji Y, Hashimoto M, Kageyama H, Terashita D, et al. Possible association between non-invasive parameter of flow-mediated dilatation in brachial artery and whole coronary plaque vulnerability in patients with coronary artery disease. Int J Cardiol 2013; 166: 613–620.","DOI":"10.1016\/j.ijcard.2011.11.101"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502–509.","DOI":"10.1161\/CIRCULATIONAHA.109.864801"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tucci SA, Boyland EJ, Halford JC. The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: A review of current and emerging therapeutic agents. Diabetes Metab Syndr Obes 2010; 3: 125–143.","DOI":"10.2147\/DMSO.S7005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, et al. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care 1998; 21: 256–260.","DOI":"10.2337\/diacare.21.2.256"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: A randomized crossover study. J Clin Endocrinol Metab 2006; 91: 837–842.","DOI":"10.1210\/jc.2005-1566"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Picard F, Deshaies Y. Postprandial serum lipids and tissue lipoprotein lipase are acutely altered in rats by the alpha-glucosidase inhibitor acarbose. Horm Metab Res 1996; 28: 377–380.","DOI":"10.1055\/s-2007-979819"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Siri-Tarino PW. Effects of diet on high-density lipoprotein cholesterol. Curr Atheroscler Rep 2011; 13: 453–460.","DOI":"10.1007\/s11883-011-0207-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, et al. The Residual Risk Reduction Initiative: A call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008; 102: 1K–34K.","DOI":"10.1016\/j.amjcard.2008.10.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Despres JP, Tremblay A, Theriault G, Perusse L, Leblanc C, Bouchard C. Relationships between body fatness, adipose tissue distribution and blood pressure in men and women. J Clin Epidemiol 1988; 41: 889–897.","DOI":"10.1016\/0895-4356(88)90106-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Uchino H, Niwa M, Shimizu T, Nishiyama K, Kawamori R. Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: Assessment using nateglinide, a new insulin secretagogue. Endocr J 2000; 47: 639–641.","DOI":"10.1507\/endocrj.47.639"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/1\/78_CJ-13-0918\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T04:11:28Z","timestamp":1616645488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/1\/78_CJ-13-0918\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-13-0918","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}